What is it about?

Clostridium difficile infection causes diarrhoea and colitis and is becoming more frequent and severe. Standard antibiotic treatments do not always work, especially when the infection keeps coming back or is complicated. Faecal microbiota transplantation (FMT) transfers stool from a healthy donor into the patient's gut to restore a normal bacterial community. Although used sporadically since the 1950s, its efficacy has only recently been proven scientifically. In this review we explain why FMT works and when it should be considered.

Featured Image

Why is it important?

FMT is cheap, effective and safe, but at the time it was still seen as an exotic procedure. By explaining its scientific basis and clinical indications, this review aimed to help clinicians consider it for difficult C. difficile cases, anticipating its later inclusion in international guidelines.

Perspectives

When we wrote this review, few people in Italy talked about FMT. It has been rewarding to see this 'unconventional' therapy become a standard recommendation for recurrent C. difficile infection in the following years.

Professor Stefano Di Bella
Universita degli Studi di Trieste

Read the Original

This page is a summary of: Fecal microbiota transplantation: the state of the art, Infectious Disease Reports, November 2013, PAGEPress Publications,
DOI: 10.4081/idr.2013.e13.
You can read the full text:

Read

Contributors

The following have contributed to this page